Body composition and prolonged hypoxia in interstitial lung disease patients

M. Quintero Martinez (Ciudad De México , Mexico), D. Gonzalez Islas (Ciudad De México , Mexico), A. Orea Tejeda (Ciudad De México , Mexico), V. Martínez Vázquez (Ciudad De México , Mexico), I. Pérez García (Ciudad De México , Mexico), N. Martínez Luna (Ciudad De México , Mexico), O. Martínez Reyna (Ciudad De México , Mexico), L. Verdeja Vendrell (Ciudad De México , Mexico), Y. Gastelum Ayala (Ciudad De México , Mexico), A. Sandoval Sánchez (Ciudad De México , Mexico), M. Gomez Martinez (Ciudad De México , Mexico), R. Sanchez Santillan (Ciudad De México , Mexico), I. Buendía Roldan (Ciudad De México , Mexico), R. Robles Hernandez (Ciudad De México , Mexico), M. Mejia Avila (Ciudad De México , Mexico)

Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Session: Prognosis and biomarkers of idiopathic pulmonary fibrosis
Session type: E-poster session
Number: 814
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Quintero Martinez (Ciudad De México , Mexico), D. Gonzalez Islas (Ciudad De México , Mexico), A. Orea Tejeda (Ciudad De México , Mexico), V. Martínez Vázquez (Ciudad De México , Mexico), I. Pérez García (Ciudad De México , Mexico), N. Martínez Luna (Ciudad De México , Mexico), O. Martínez Reyna (Ciudad De México , Mexico), L. Verdeja Vendrell (Ciudad De México , Mexico), Y. Gastelum Ayala (Ciudad De México , Mexico), A. Sandoval Sánchez (Ciudad De México , Mexico), M. Gomez Martinez (Ciudad De México , Mexico), R. Sanchez Santillan (Ciudad De México , Mexico), I. Buendía Roldan (Ciudad De México , Mexico), R. Robles Hernandez (Ciudad De México , Mexico), M. Mejia Avila (Ciudad De México , Mexico). Body composition and prolonged hypoxia in interstitial lung disease patients. 814

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Body mass index predicts survival in patients with pulmonary hypertension in chronic lung disease
Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Year: 2019


Body composition and pulmonary function in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 626s
Year: 2006

Impact of body weight on lung volumes in patients with pulmonary diseases
Source: Annual Congress 2010 - Lung morbidity on exposure to various agents
Year: 2010

Compartments distribution of body composition in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015

Body composition methods in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2007 - Clinical aspects of idiopathic pulmonary fibrosis
Year: 2007


Body composition in heart failure and chronic obstructive pulmonary disease patients
Source: International Congress 2017 – Techniques to treat asthma
Year: 2017


Low body mass index in hospitalised patients with chronic obstructive pulmonary disease (COPD): is related to low lung function and increased mortality
Source: Eur Respir J 2006; 28: Suppl. 50, 66s
Year: 2006

Alterations in metabolism and body composition in chronic respiratory diseases
Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=11
Year: 2003

Body composition assessment in COPD and pulmonary hypertension patients
Source: International Congress 2017 – Imaging and lung disease PH
Year: 2017

Isolated reduction in residual volume on body plethysmography is an early indicator of parenchymal lung disease
Source: International Congress 2016 – Pathophysiological mechanisms at different levels: lung, airways, muscles and symptom perception
Year: 2016


Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Ultrasonographic assessment of the diaphragm in patients with chronic obstructive pulmonary disease (COPD): Relationships with pulmonary function and the influence of body composition
Source: Annual Congress 2012 - Functional imaging in pulmonary oncology and COPD. Radiation dose in chest CT: survey and real life
Year: 2012


Relationship between loss of body weight and impairment of tissue oxygenation in patients with pulmonary emphysema
Source: Eur Respir J 2003; 22: Suppl. 45, 537s
Year: 2003

Cardiac muscle mass and function are associated with altered body composition in patients with COPD
Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation
Year: 2007


Pulmonary vascular response patterns during exercise in interstitial lung disease
Source: Eur Respir J 2015; 46: 738-749
Year: 2015



Does hypoxemia increases risks in hospitalized patients with diffuse interstitial lung disease?
Source: International Congress 2014 – ILDs 6
Year: 2014

Lung function and body weight influence the outcome of pulmonary rehabilitation in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 356s
Year: 2001

Body composition in chronic obstructive pulmonary disease and heart failure
Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD
Year: 2018

Does body mass index influence survival of patients with idiopathic pulmonary fibrosis?
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018

Influence of body mass index in exercise capacity in patients with chronic obstructive pulmonary disease under pulmonary rehabilitation
Source: International Congress 2017 – Latest insights into functional capacity, muscle weakness and physical activity in chronic lung diseases
Year: 2017